While additional patients will be needed to define the full spectrum of human PGBD5 deficiency syndrome, these findings indicate that PGBD5 mutations are associated with developmental delay, intellectual disability, ataxia-dystonia, and epilepsy. The gene discussed is PGBD5; the disease is epilepsy.